Results 111 to 120 of about 1,513 (131)

Mitragyna Species as Pharmacological Agents: From Abuse to Promising Pharmaceutical Products

Life, 2022
Anton Rahmadi, Fajar Prasetya, Prabowo Wisnu Cahyo   +2 more
exaly  

Assessing the Therapeutic Potential and Toxicity of Mitragyna speciosa in Opioid Use Disorder

Expert Opinion on Drug Metabolism and Toxicology, 2021
Christopher R McCurdy, Abhisheak Sharma
exaly  

Mitragyna speciosa

Reactions Weekly, 2020
openaire   +2 more sources

The Mitragyna Species of Asia

Planta Medica, 1978
P J Houghton, E J Shellard, P Houghton
exaly   +2 more sources

Development of a Physiologically Based Pharmacokinetic Model of Mitragynine, Psychoactive Alkaloid in Kratom (Mitragyna speciosa Korth.), in Rats and Humans

Journal of Psychoactive Drugs, 2021
Janthima Methaneethorn, Tran Quoc Ba, Winai Wananukul   +2 more
exaly  

The Use of Benzodiazepines Among Kratom (Mitragyna speciosa Korth.) Users

Journal of Psychoactive Drugs, 2020
Edward W Boyer, Darshan Singh, Suresh Narayanan   +2 more
exaly  

Factor Analytical Investigation of Krathom (Mitragyna speciosa Korth.) Withdrawal Syndrome in Thailand

Journal of Psychoactive Drugs, 2016
Alan Geater, Sawitri Assanangkornchai, Darika Saingam   +2 more
exaly  

Acute Toxicity Study of the Standardized Methanolic Extract of Mitragyna speciosa Korth in Rodent

Journal of Ethnopharmacology, 2010
Jafri M. Abdullah
exaly  

Phytochemical Characterization of the Leaves of Mitragyna speciosa Grown in USA

Natural Product Communications, 2009
Christopher R McCurdy, Francisco León, Stephen J Cutler   +2 more
exaly  

Severity of Pain and Sleep Problems During Kratom (Mitragyna speciosa Korth.) Cessation Among Regular Kratom Users

Journal of Psychoactive Drugs, 2018
Hadzliana Zainal, Sabariah N Harun, Darshan Singh   +2 more
exaly